These could both be investigated in the context of therapeutics like metyrapone, a GC inhibitor, which could alleviate these effects while maintaining adequate anti-tumor effects, while also allowing for evaluation of the mechanisms underlying GC mediated involution. This evidence concerns the gene GC and neoplasm.